Nexalis Therapeutics Limited has released a press release.
Jun26 Appendix 4C Cash Flow Report
Earlier from Nexalis Therapeutics
- Update on Funding Facility and Clinical Program
- Binding Letter of Intent to replace existing $53m facility
- Suspension from Quotation
- Mar26 Appendix 4C Cash Flow Report